In the latest trading session,, 0.65 million Pharvaris NV (NASDAQ:PHVS) shares changed hands as the company’s beta touched -2.80. With the company’s most recent per share price at $21.17 changed hands at -$1.95 or -8.43% at last look, the market valuation stands at $1.15B. PHVS’s current price is a discount, trading about -24.37% off its 52-week high of $26.33. The share price had its 52-week low at $11.51, which suggests the last value was 45.63% up since then. When we look at Pharvaris NV’s average trading volume, we note the 10-day average is 0.11 million shares, with the 3-month average coming to 81.52K.
Analysts gave the Pharvaris NV (PHVS) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.27. If we narrow down to specifics, the data shows that 0 out of 4 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended PHVS as a Hold, 4 felt it is a Buy and 0 rated the stock as Underweight.
Pharvaris NV (NASDAQ:PHVS) trade information
Instantly PHVS was in red as seen in intraday trades today. With action -7.96%, the performance over the past five days has been red. The company’s shares are showing year-to-date upside of 15.31%, with the 5-day performance at -7.96% in the red. However, in the 30-day time frame, Pharvaris NV (NASDAQ:PHVS) is 21.53% up. Looking at the short shares, we see there were 0.79 million shares sold at short interest cover period of 14.16 days.
The consensus price target for the stock as assigned by Wall Street analysts is 42, meaning bulls need an upside of 49.6% from its recent market value. According to analyst projections, PHVS’s forecast low is 27 with 50 as the target high. To hit the forecast high, the stock’s price needs a -136.18% plunge from its current level, while the stock would need to soar -27.54% for it to hit the projected low.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -7.73%. The 2025 estimates are for Pharvaris NV earnings to decrease by -21.67%, but the outlook for the next 5-year period is at 2.97% per year.
PHVS Dividends
Pharvaris NV is expected to release its next quarterly earnings report on 2025-May-13.
Pharvaris NV (NASDAQ:PHVS)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 6.25% of Pharvaris NV shares while 89.49% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 95.46%. There are 89.49% institutions holding the Pharvaris NV stock share, with GENERAL ATLANTIC, L.P. the top institutional holder. As of 2024-06-30, the company held 13.9943% of the shares, roughly 7.53 million PHVS shares worth $141.59 million.
FMR LLC holds the second largest percentage of outstanding shares, with 9.6729% or 5.21 million shares worth $97.87 million as of 2024-06-30.
Among Mutual Funds, the top two as of May 31, 2025 were Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund and Fidelity Select Portfolios-Health Care Portfolio . With 1.01 shares estimated at $21.53 million under it, the former controlled 1.86% of total outstanding shares. On the other hand, Fidelity Select Portfolios-Health Care Portfolio held about 1.37% of the shares, roughly 746.75 shares worth around $15.85 million.
